CAS 1199236-64-0

N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide

CAS: 1199236-64-0

Formula: C₁₉H₂₇ClFN₃O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 383.8880

Ref: IN-DA008X5A

Z944

CAS: 1199236-64-0

Z944

Purity: ≥98%

Molecular weight: 383.89g/mol

Ref: 54-BUP03864

Z944

CAS: 1199236-64-0

Z944 is a T-type calcium channel blocker.

Formula: C₁₉H₂₇ClFN₃O₂

Purity: 99.8% - 99.80%

Color and Shape: Solid

Molecular weight: 383.89

Ref: TM-T29201

N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide

Controlled Product

CAS: 1199236-64-0

Applications N-Piperidinyl acetamide derivatives as calcium channel blockers and their use in the treatment of obesity.
References Lopez-Rodriguez, et al.: Bioorg. Med. Chem. Lett., 11, 2807 (2001), Yang, et al.: J. Med. Chem., 51, 6471 (2008),

Formula: C₁₉H₂₇ClFN₃O₂

Color and Shape: Off White Solid

Molecular weight: 383.89

Ref: TR-B690665

N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide

CAS: 1199236-64-0

N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide is a novel antiarrhythmic drug that inhibits the activation of cardiac cells. It was shown to inhibit proliferation and migration of human leukemia cells in vitro and to inhibit tumor growth in vivo. N-(1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide has been shown to have cardioprotective effects in Sprague Dawley rats, reducing the incidence of ventricular tachycardia and fibrillation. The clinical studies conducted so far have not revealed any adverse effects on the heart or other organs.

Formula: C₁₉H₂₇ClFN₃O₂

Purity: Min. 95%

Color and Shape: White Solid

Molecular weight: 383.89 g/mol

Ref: 3D-FB19507